Ciproplit Eye Drops contain Ciprofloxacin 0.3% w/v, a broad-spectrum fluoroquinolone antibiotic formulated to effectively treat bacterial eye infections including conjunctivitis, blepharitis, and corneal ulcers. Its targeted ophthalmic formulation ensures rapid antibacterial action with high ocular safety.
Ciprofloxacin works by inhibiting bacterial DNA gyrase, leading to rapid eradication of susceptible pathogens and helping to reduce infection-related redness, discharge, and irritation.
From a business perspective, Ciproplit Eye Drops are a high-prescription ophthalmic antibiotic, widely used in hospitals, eye clinics, and general ophthalmology practice, ensuring consistent demand and repeat prescriptions.
Adding Ciproplit Eye Drops to your portfolio strengthens the ophthalmic anti-infective segment, delivering reliable turnover, strong prescriber acceptance, and long-term franchise growth.